2024 US Cell Surface Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Emerging Opportunities
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.
I. Introduction
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8/CD34
° Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. HEMATOLOGY ANALYZERS
a. Overview
° Electrical Aperture-Impedance Analyzers
° Light Scatter Analyzers
b. System Review
° Abbott
° Beckman Coulter/Danaher
° Biocode Hycel
° Drew-Scientific
° Horiba
° Menarini
° Nihon Kohden
° Siemens
° Sysmex
2. FLOW CYTOMETERS
a. Introduction
b. System Overview
° Becton Dickinson
° Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. INFORMATION TECHNOLOGIES
2. AUTOMATION AND ROBOTICS
3. LASERS
4. ARTIFICIAL INTELLIGENCE
5. MONOCLONAL ANTIBODIES
6. MOLECULAR DIAGNOSTICS
7. MICRODROP TECHNOLOGY
III. U.S. : Forecasts by Test and Market Segment
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. FOUR MARKETING APPROACHES
2. PRODUCT COMPLEXITY FACTOR
3. CUSTOMER PREFERENCE FACTOR
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION FACTOR
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8/CD34
° Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. HEMATOLOGY ANALYZERS
a. Overview
° Electrical Aperture-Impedance Analyzers
° Light Scatter Analyzers
b. System Review
° Abbott
° Beckman Coulter/Danaher
° Biocode Hycel
° Drew-Scientific
° Horiba
° Menarini
° Nihon Kohden
° Siemens
° Sysmex
2. FLOW CYTOMETERS
a. Introduction
b. System Overview
° Becton Dickinson
° Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. INFORMATION TECHNOLOGIES
2. AUTOMATION AND ROBOTICS
3. LASERS
4. ARTIFICIAL INTELLIGENCE
5. MONOCLONAL ANTIBODIES
6. MOLECULAR DIAGNOSTICS
7. MICRODROP TECHNOLOGY
III. U.S. : Forecasts by Test and Market Segment
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. FOUR MARKETING APPROACHES
2. PRODUCT COMPLEXITY FACTOR
3. CUSTOMER PREFERENCE FACTOR
4. ESTABLISHED SUPPLIERS
5. EMERGING SUPPLIERS
6. MAJOR TYPES OF DISTRIBUTORS
7. MARKET SEGMENTATION FACTOR
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
